Abiopharma

🔍 White Steven Andrew (Director)

Company: W.W. GRAINGER, INC. (GWW)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 5 shares of Deferred Stock Units (Derivative)
  Date: 2026-09-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 5 shares of Deferred Stock Units (Derivative)
  Date: 2026-09-01 | Code: G | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Acquired 5 shares of Deferred Stock Units (Derivative)
  Date: 2026-09-01 | Code: G | equity_swap_involved: 0 | shares_owned_after: 2,924.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3

Footnotes:

• F1: 1-for-1
• F2: The deferred stock units are expected to settle in shares of common stock on a one-for-one basis following end of service as a director.
• F3: The stock units were gifted to the reporting person's spouse and were subsequently transferred by the spouse into a family trust of which the reporting person is trustee and primary beneficiary. The reporting person has voting and investment power with respect to all stock units held by the family trust.